NuVasive, Inc.
NUVA
NUVA was delisted on the 31st of August, 2023.
156 hedge funds and large institutions have $1.07B invested in NuVasive, Inc. in 2013 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 68 increasing their positions, 56 reducing their positions, and 24 closing their positions.
1,990% more call options, than puts
Call options by funds: $35.2M | Put options by funds: $1.69M
21% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 56
3% more capital invested
Capital invested by funds: $1.04B → $1.07B (+$32.9M)
7% less funds holding
Funds holding: 168 → 156 (-12)
46% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 24
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$20M |
| 2 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$18.5M |
| 3 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$10.8M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$10.8M |
| 5 |
JP Morgan Chase
New York
|
+$10.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$25.2M |
| 2 |
RSCM
Rail-Splitter Capital Management
Chicago,
Illinois
|
-$7.47M |
| 3 |
Morgan Stanley
New York
|
-$6.89M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$5.1M |
| 5 |
Two Sigma Investments
New York
|
-$5.1M |
NUVA Hedge Fund Activity: Q3 2013 in Review
156 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in NuVasive, Inc. (NUVA) for Q3 2013, worth a combined $1.07B — up 3.2% from $1.04B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of NUVA and 13 opened new positions — a net loss of 11 holders — while 56 trimmed existing stakes and 68 added.
The largest buyer was Federated Hermes, adding an estimated $20M. The largest seller was HealthCor Management, cutting an estimated $25.2M.
- 156 institutional investors held NuVasive, Inc. (NUVA) as of Q3 2013, down from 168 in Q2 2013.
- Funds reported $1.07B of NuVasive, Inc. stock for Q3 2013, up 3.2% quarter-over-quarter.
- 13 funds opened new NuVasive, Inc. positions in Q3 2013 and 24 closed out, a net change of -11 holders.
- The largest NuVasive, Inc. buyer in Q3 2013 was Federated Hermes, an estimated $20M added.
- The largest NuVasive, Inc. seller in Q3 2013 was HealthCor Management, an estimated $25.2M sold.
Based on aggregated 13F filings for Q3 2013.